Protein kinase C and other diacylglycerol effectors in cancer
The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Abstract
Almost three decades after the discovery of protein kinase C (PKC), we still have only a partial understanding of how this family of serine/threonine kinases is involved in tumour promotion. PKC isozymes - effectors of diacylglycerol (DAG) and the main targets of phorbol-ester tumour promoters - have important roles in cell-cycle regulation, cellular survival, malignant transformation and apoptosis. How do PKC isozymes regulate these diverse cellular processes and what are their contributions to carcinogenesis? Moreover, what is the contribution of all phorbol-ester effectors, which include PKCs and small G-protein regulators? We now face the challenge of dissecting the relative contribution of each DAG signal to cancer progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IP3 triggers calcium release from intracellular stores, while DAG activates protein kinase C (PKC) and other effector proteins, ultimately influencing microglial processes such as migration, phagocytosis, cytokine secretion, and metabolic responses. 13 , 16 , 17”
From Alzheimer's disease–associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell–derived microglia‐like cells (2025) · cites this paper as [17]
In the citing paper
“and DAG leading to activation of protein kinase C (PKC) isozymes, the NLRP3 inflammasome [31, 34], as well as other proteins [77].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [77]
In the citing paper
“Conversely, phorbol esters, the naturally occurring activating ligands of PKC, showed tumor‐promoting functions, suggesting that PKC could be an oncogene [111, 120, 121].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [121]
Citations
Cites
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., & Nishizuka, Y. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34459-4 · Cited by 4,725 · cited 3×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
BackgroundKishimoto, A., Takai, Y., Mori, T., Kikkawa, U., & Nishizuka, Y. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85886-6 · Cited by 1,303
Protein kinase C as a possible receptor protein of tumor‐promoting phorbol esters
Kikkawa, U., Takai, Y., Tanaka, Y., Miyake, R., & Nishizuka, Y. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44245-1 · Cited by 881 · cited 2×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm
NEWTON, A. C. (2003) · Biochemical Journal · doi:10.1042/bj20021626 · Cited by 798
Takai, Y., Kishimoto, A., Kikkawa, U., Mori, T., & Nishizuka, Y. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91197-5 · Cited by 731 · cited 1×
“Nishizuka and colleagues found that PKC could be activated by the lipid diacylglycerol (DAG) in the presence of phosphatidylserine as a cofacto”
BackgroundRasGRP, a Ras Guanyl Nucleotide- Releasing Protein with Calcium- and Diacylglycerol-Binding Motifs
Ebinu, J. O., Bottorff, D. A., Chan, E. Y. W., Stang, S. L., Dunn, R. J., & Stone, J. C. (1998) · Science · doi:10.1126/science.280.5366.1082 · Cited by 689
Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells.
Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., Ghayur, T., Wong, W. W., Kamen, R., & Weichselbaum, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00305.x · Cited by 670
Multiple pathways control protein kinase C phosphorylation
Parekh, D. B., Ziegler, W., & Parker, P. J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.496 · Cited by 601 · cited 1×
“The mechanisms involved in PKC activation have been extensively studie”
BackgroundTakahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119006 · Cited by 566 · cited 1×
“Several PKC isoforms, including PKCα, β and e, are activated in response to VEGF receptor activation, and PKC has been implicated as an important mediator of VEGF-induced proliferation of endothelial cell”
Background
Research works printed but not linked: 1
- Wu, E. X. et al. PKCβ: a rational therapeutic target in diffuse large B-cell lymphoma. Blood 100, 202A–202A (2002).
Cited by
Items 701–800 of 1,000
Amedei, A., & Niccolai, E. (2014) · Wiley eBooks · doi:10.1002/9781118876015.ch4 · Cited by 10
Protective effect of truncated Na+/K+‐ATPase β on ischemia/reperfusion-induced renal injury in rats
Gong, H., Sun, J., Xue, W., Tian, P., Ding, X., Yan, H., Li, Y., & Zheng, J. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370213517613 · Cited by 7
Trinuclear Calcium Site in the C2 Domain of PKCα/γ Is Prone to Lithium Attack
Grauffel, C., Weng, W.-H., Dudev, T., & Lim, C. (2021) · ACS Omega · doi:10.1021/acsomega.1c02882 · Cited by 7
Ibnat, N., Islam, R. A., & Chowdhury, E. H. (2021) · Applied Sciences · doi:10.3390/app11178133 · Cited by 7
Multiple subcellular localizations and functions of protein kinase Cδ in liver cancer
Yamada, K., & Yoshida, K. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i2.188 · Cited by 8
Azbazdar, Y., Tejeda‐Muñoz, N., Monka, J., Dayrit, A., Binder, G., Özhan, G., & Robertis, E. M. D. (2023) · iScience · doi:10.1016/j.isci.2023.108075 · Cited by 7
“46 Many mutations in enzymes that regulate DAG are associated with cancer.”
BackgroundMethods for Studying Oxidative Regulation of Protein Kinase C
Gopalakrishna, R., McNeill, T. H., Elhiani, A. A., & Gundimeda, U. (2013) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-405881-1.00005-7 · Cited by 7
Modulation of Pancreatic Tumor Potential by Overexpression of Protein Kinase C β1
Cirigliano, S. M., Mauro, L. V., Grossoni, V. C., Colombo, L. L., Diament, M., Kazanietz, M. G., Joffé, E. B. D. K., Puricelli, L., & Urtreger, A. J. (2013) · Pancreas · doi:10.1097/mpa.0b013e31828fd141 · Cited by 7
Self-citationProtein kinase Cδ in tumorigenesis of human malignant fibrous histiocytoma
Kawamoto, T. (2011) · Oncology Reports · doi:10.3892/or.2011.1415 · Cited by 9
PKCα inhibited apoptosis by decreasing the activity of JNK in MCF-7/ADR cells
Wang, N., Li, Z., Tian, F., Feng, Y., Huang, J., Li, C., & Xie, F. (2010) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2010.10.014 · Cited by 7
Wang, Y., Sun, G., Ji, Z., Xing, C., & Liang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029860 · Cited by 7
“Some genes themselves have not yet been reported, but their related genes, proteins, or behaviors have been reported as cancer-relevant, such as DGKD (EGFR and DAG related, ranked 481) [20].”
BackgroundRegulation of PKD1‐mediated Golgi to cell surface trafficking by Gαq subunits
Coria, A. S., Masseroni, M. L., & Añel, A. M. D. (2013) · Biology of the Cell · doi:10.1111/boc.201300052 · Cited by 7
“In this system, the DAG produced would have a double role, the activation of PKC and, as previously described (Griner and Kazanietz, 2007), the recruitment of PKD1 to Golgi membranes (Figure 7).”
BackgroundPKC and the Control of Apoptosis
Reyland, M. E., & Bradford, A. P. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_9 · Cited by 10
Differential targeting of cPKC and nPKC decodes and regulates Ca2+ and lipid signalling
Hui, X., Kaestner, L., & Lipp, P. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140239 · Cited by 7
Mode of action of Jatropha curcas phorbol esters in bovine kidney cells
Oskoueian, E., Abdullah, N., Noura, R., Ebrahimi, M. M., Ahmad, S., & Shakeri, M. (2019) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2019.01.010 · Cited by 7
PKCδ mediates thrombin-augmented fibroblast-mediated collagen gel contraction
Fang, Q., Mao, L., Kobayashi, T., Wang, X., Wyatt, T. A., Kim, H., Liu, X., & Rennard, S. I. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.016 · Cited by 7
“PKCδ is a pro-apoptotic or growth inhibitory PKC, and many types of apoptotic stimuli can induce PKCδ translocation to mitochondria, leading to cytochrome c release and caspase-3 activation [23,32].”
BackgroundMechanisms of Panax ginseng in preventing rat pheochromocytoma cells from apoptosis
Lin, Y., Huang, C., Lee, Y., Liao, W.-C., Lai, W.-L., Lin, Y., & Huang, N. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.06.029 · Cited by 7
A Multimodel Study of the Role of Novel PKC Isoforms in the DNA Integrity Checkpoint
Saiz-Baggetto, S., Edo, L. D., Méndez, E., García-Bolufer, P., Marí, M., Bañó, M. C., Fariñas, I., Morante‐Redolat, J. M., Igual, J. C., & Quilis, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115796 · Cited by 6
“Given all these functions, its complex relationship with cancer is evident [52,57] as it has generally been proposed as a tumor suppressor, yet oncogenic characteristics have also been attributed to it.”
BackgroundWang, J., Weng, S., Zhu, Y., Chen, H., Pan, J., Qiu, S., Liu, Y., Wei, D., & Zhu, T. (2023) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-023-00780-9 · Cited by 6
“Protein kinase C isoform ι (PKCι) belongs to the atypical kinase C subfamily, which is insensitive to co-factors such as calcium or diacylglycerol, but relies on protein–protein interaction for activation (Griner et al. 2007; Moscat et al. 2009; Ono et al. 1998).”
BackgroundFan, S., Kang, B., Li, S., Li, W., Chen, C., Chen, J., Deng, L., Chen, D., & Zhou, J. (2024) · Cell Cycle · doi:10.1080/15384101.2024.2366009 · Cited by 6
“This process triggers a structural rearrangement between the CDC25 and EF domains of RASGRP1, resulting in reduced autoinhibition stability [35].”
BackgroundProtein Kinase C Epsilon and Genetic Networks in Osteosarcoma Metastasis
Goudarzi, A., Gökgöz, N., Gill, M., Pinnaduwage, D., Merico, D., Wunder, J. S., & Andrulis, I. L. (2013) · Cancers · doi:10.3390/cancers5020372 · Cited by 6
“This mature form of the enzyme is cytosolic and in an auto-inhibited ‘closed’ confirmation, as its active site is engaged by binding to its pseudosubstrate domain [199, 200, 232].”
BackgroundInfluentialPu, Y., Kang, J., Sigano, D. M., Peach, M. L., Lewin, N. E., Márquez, V. E., & Blumberg, P. M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500165n · Cited by 6
Smith, M. D., & Best, M. D. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-151-2_30 · Cited by 6
Inhibition of protein kinase C activity inhibits osteosarcoma metastasis
Hu, H.-J., Deng, X., Li, R.-X., Chen, D.-W., & Xue, C. H. (2018) · Archives of Medical Science · doi:10.5114/aoms.2018.79450 · Cited by 6
“(S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione(LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.”
Gatsinzi, T., Ivanova, E. V., & Iverfeldt, K. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0932-2 · Cited by 6
“Further, since both curcumin and STS have been reported to be involved in the inhibition of PKC [18, 22], and PKC is known to play a crucial role in several different cancer forms [29], we hypothesized that PKC could also be involved in the inhibition of the proper activation of caspase-3 in human neuroblastoma SK-N-A…”
BackgroundTalman, V., Provenzani, R., af Gennäs, G. B., Tuominen, R. K., & Yli‐Kauhaluoma, J. T. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140181 · Cited by 6
Roles of PKC Isoforms in PMA-Induced Modulation of the hERG Channel (Kv11.1)
Radresa, O., Guia, A., & Baroudi, G. (2014) · SLAS DISCOVERY · doi:10.1177/1087057113520227 · Cited by 6
“(4) The tube was then centrifuged at 600 to 800 g relative centrifugal force (RCF) (~14 cm radius) for 1 min and the supernatant removed.”
BackgroundMethodInfluentialCharge Density Influences C1 Domain Ligand Affinity and Membrane Interactions
Kelsey, J. S., Géczy, T., Lewin, N. E., Kedei, N., Hill, C., Selezneva, J. S., Valle, C. J., Woo, W., Gorshkova, I. I., & Blumberg, P. M. (2014) · ChemBioChem · doi:10.1002/cbic.201400041 · Cited by 6
Kedei, N., Chen, J.-Q., Herrmann, M. A., Telek, A., Goldsmith, P. K., Petersen, M. E., Keck, G. E., & Blumberg, P. M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500417b · Cited by 6
Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival
Li, H., Wang, Y., Liu, H., Shi, Q., Li, H., Wu, W., Zhu, D. K., Amos, C. I., Fang, S., Lee, J. E., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20245 · Cited by 6
“For example, PRKCD can be a suppressor in a few cancer types [33, 36], but over-expression of PRKCD increased the metastatic potential of murine BL16 mouse melanoma cells [37, 38].”
BackgroundCalderon, C., Torroella‐Kouri, M., Dinapoli, M. R., & Lopez, D. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.3.713 · Cited by 6
APOBEC3B Is Co-Expressed with PKCα/NF-κB in Oral and Oropharyngeal Squamous Cell Carcinomas
Fanourakis, G., Kyrodimos, E., PAPANIKOLAOU, V. S., Chrysovergis, A., Kafiri, G., Papanikolaou, N., Verykokakis, M., Tosios, K. I., & Vastardis, H. (2023) · Diagnostics · doi:10.3390/diagnostics13030569 · Cited by 5
“Human cells may express up to nine different PKC genes [15,16] that are divided into three subfamilies, i.”
BackgroundFast Antioxidation Kinetics of Glutathione Intracellularly Monitored by a Dual‐Wire Nanosensor
Jiao, Y., Kang, Y., Wen, M., Wu, H., Zhang, X., & Huang, W. (2023) · Angewandte Chemie · doi:10.1002/ange.202313612 · Cited by 5
Massey, S., Kongchan, N., Gao, Y., Chaudhury, A., Olokpa, E., Karch, J. M., Malovannaya, A., Cheng, C., Zhang, X. H.-F., & Neilson, J. R. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107826 · Cited by 5
“PKC a belongs to the “ classical ” (Ca 2+ -dependent) and PKC ε to the “ novel ” (Ca 2+ -independent) subclasses of the PKC family, meaning that their activity requires different cofactors and stimulatory signals (39).”
Fatma, M., Parveen, S., & Mir, S. S. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189309 · Cited by 5
Influence of protein kinase C (PKC) on the prognosis of diabetic nephropathy patients.
Yang, J., & Zhang, J. (2015) · PubMed · Cited by 5
Yeo, M., Kim, J., Seong, I., Kim, J., & Kim, K. (2017) · Journal of Cancer · doi:10.7150/jca.20983 · Cited by 5
“The last atypical PKC (aPKC) isoforms are independent of calcium (Ca2+) and diacylglycerol (DAG) compared to other PKCs, which require Ca2+ or DAG for activation [2, 3].”
BackgroundZhao, X., Kedei, N., Michalowski, A., Lewin, N. E., Keck, G. E., & Blumberg, P. M. (2018) · ChemBioChem · doi:10.1002/cbic.201700677 · Cited by 5
Caspases interplay with kinases and phosphatases to determine cell fate
Akbari‐Birgani, S., Khademy, M., Mohseni‐Dargah, M., Madadi, Z., Mokhtar-Ahmadabadi, R., & Davoodi-Monfared, P. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.04.048 · Cited by 5
Regulation of Conventional and Novel Protein Kinase C Isozymes by Phosphorylation and Lipids
Newton, A. C. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_2 · Cited by 5
“…reactions (PHLPP) alter the levels of protein kinase C. Protein kinase C levels are altered in many pathophysiological states, most notably cancer (Griner and Kazanietz 2007), suggesting that the mechanisms that control the phosphorylation/dephosphorylation are potential therapeutic targets.”
Mamidi, N., Panda, S., Borah, R., & Manna, D. (2014) · Molecular BioSystems · doi:10.1039/c4mb00382a · Cited by 5
Palytoxin Induces Dissociation of HSP 27 Oligomers through a p38 Protein Kinase Pathway
Berni, C., Bellocci, M., Sala, G. L., & Rossini, G. P. (2015) · Chemical Research in Toxicology · doi:10.1021/tx500511q · Cited by 5
Klos, K. S., Warmka, J. K., Drachenberg, D. M., Chang, L., Luxton, G. W. G., Leung, C. T., Schwertfeger, K. L., & Wattenberg, E. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090722 · Cited by 5
“Both PKCa and PKCd can block proliferation, although PKCd can also stimulate proliferation and death, depending on the system [5].”
BackgroundInfluentialCole, T. R., & Igumenova, T. I. (2015) · Protein Expression and Purification · doi:10.1016/j.pep.2014.12.018 · Cited by 5
Sand, J. M., Hafeez, B. B., Aziz, M. H., Siebers, E. M., Dreckschmidt, N. E., & Verma, A. K. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20776 · Cited by 6
“Protein kinase C (PKC), a family of phospholipid-dependent serine/threonine (Thr) kinases, is not only the major intracellular receptor for the mouse skin tumor promoter 12-Otetradecanoylphorbol-13-acetate (TPA) [5–9] but also is activated by a variety of stress factors including UVR [10].”
BackgroundPromotion of mouse two-stage skin carcinogenesis by diacylglycerol-rich edible oil
Takasuka, N., Takahashi, M., Hori, Y., Kitahashi, T., Iigo, M., Imai, T., Yoshimi, N., Sügimura, T., & Wakabayashi, K. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.016 · Cited by 5
“Activators of protein kinase C (PKC), such as 12-O-tetradecanoylphorbol-13-acetate (TPA), are known to have tumor-promoting activity [8].”
BackgroundMolecular characterization of protein kinase C delta (PKCδ)-Smac interactions
Holmgren, C., Cornmark, L., Lønne, G. K., Masoumi, K. C., & Larsson, C. (2016) · BMC Biochemistry · doi:10.1186/s12858-016-0065-x · Cited by 5
“C1 domains bind diacylglycerol whereas C2 domains bind calcium ions, both of which serve as activators of PKC function [13].”
PKC η deficiency improves lipid metabolism and atherosclerosis in apolipoprotein E ‐deficient mice
Torisu, K., Zhang, X., Nonaka, M., Kaji, T., Tsuchimoto, D., Kajitani, K., Sakumi, K., Torisu, T., Chida, K., Sueishi, K., et al. (2016) · Genes to Cells · doi:10.1111/gtc.12402 · Cited by 5
“There is significant evidence linking PKCg to cellular differentiation (Ohba et al. 1998; Chida et al. 2003), cell cycle regulation (Fima et al. 2001), cell survival, malignant transformation and apoptosis (Griner & Kazanietz 2007).”
BackgroundEfficient PKC inhibitor screening achieved using a quantitative CE‐LIF assay
Nguyen, B. T., Park, M., Pyun, J., Yoo, Y. S., & Kang, M. (2016) · Electrophoresis · doi:10.1002/elps.201600330 · Cited by 5
Lipid Metabolism, Lipid Signalling and Longevity
Duffy, J., Mutlu, A. S., & Wang, M. C. (2016) · Healthy ageing and longevity · doi:10.1007/978-3-319-44703-2_14 · Cited by 5
Alexander, P. M., Caudell, D. L., Kucera, G. L., Pladna, K. M., & Pardee, T. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179798 · Cited by 5
The C1 domain of Vav3, a novel potential therapeutic target
Kelsey, J. S., Géczy, T., Kaler, C. J., & Blumberg, P. M. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.09.008 · Cited by 5
Song, X., Qi, X., Wang, Q., Zhu, W., & Li, J. (2017) · Europe PMC (PubMed Central) · Cited by 7
Platelets in the pathogenesis of vascular disease and their role as a therapeutic target
Prabhu, S., Sharma, R. P., & Peter, K. (2011) · University of Adelaide Press eBooks · doi:10.1017/upo9781922064004.012 · Cited by 5
Chow, S., Krainz, T., Bettencourt, C. J., Broit, N., Ferguson, B., Zhu, M., Hull, K. G., Pierens, G. K., Bernhardt, P. V., Parsons, P. G., et al. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202003221 · Cited by 6
PKC and Control of the Cell Cycle
Black, J. D. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_8 · Cited by 7
Philosof‐Mazor, L., Volinsky, R., Comin, M. J., Lewin, N. E., Kedei, N., Blumberg, P. M., Márquez, V. E., & Jelinek, R. (2008) · Langmuir · doi:10.1021/la802204n · Cited by 5
Dual role for Id2 in chemical carcinogen-induced skin tumorigenesis
Tokuriki, A., Iyoda, T., Inaba, K., Ikuta, K., Fujimoto, S., Kumakiri, M., & Yokota, Y. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp172 · Cited by 6
Regulation of the biochemical function of motif VI of HCV NTPase/helicase by the conserved Phe-loop
Hartjen, P., Medom, B. K., Reinholz, M., Borowski, P., & Baier, A. (2008) · Biochimie · doi:10.1016/j.biochi.2008.09.007 · Cited by 4
“It is well documented that such disturbance of the functions of PKC, if permanent, can lead to the development of a tumor phenotype and other diseases [7,8].”
BackgroundPelletier, G., Padhi, B. K., Hawari, J. A.-A., Sunahara, G. I., & Poon, R. W. M. (2015) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-014-9861-z · Cited by 8
“2, TPA directly binds and activates PKC (Griner and Kazanietz 2007).”
BackgroundLiu, D., Wang, C., Chen, Y., Huang, X., Wen, Y., Duan, S., Cai, Y., Li, X., He, J., Han, K., et al. (2025) · Cardiovascular Toxicology · doi:10.1007/s12012-025-09995-1 · Cited by 4
“In many cases, altered PKC expression may be associated with disease progression [9], where isozyme alpha, epsilon, and zeta play a major role in antitumor therapy and apoptosis [31].”
Toxicidade do pericarpo da Jatropha curcas em ovinos
Ferreira, O. R., Brito, S. S., Lima, F. G., de Souza, D. P. M., Mendonça, S., Ribeiro, J. A. D. A., Maiorka, P. C., Araújo, V. L., Neiva, J. N. M., Fíoravantí, M. C. S., et al. (2012) · Arquivo Brasileiro de Medicina Veterinária e Zootecnia · doi:10.1590/s0102-09352012000300006 · Cited by 4
516: Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells
Brusevold, I. J., Tveteraas, I. H., Aasrum, M., Ødegård, J., Sandnes, D., & Christoffersen, T. (2014) · European Journal of Cancer · doi:10.1016/s0959-8049(14)50459-5 · Cited by 4
Torta de pinhão-manso (Jatropha curcas): implicações hepatotóxicas
Honorato, C. A., da Silva, C. J., Quintana, C. F., Mendonça, S., Nascimento, C. A., Marcondes, V. M., Parente, B. O., & de Araújo, M. A. M. (2017) · Brazilian Journal of Veterinary Research and Animal Science · doi:10.11606/issn.1678-4456.bjvras.2017.79390 · Cited by 4
Lu, Y., Lin, C., Su, S., Ho, Y., Yeh, F.-L. J., Hsin, C., & Yang, S. (2024) · Oral Oncology · doi:10.1016/j.oraloncology.2024.107038 · Cited by 4
Basu, A., Persaud, S. D., & Sivaprasad, U. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)01608-x · Cited by 4
PKCδ knockdown inhibits free fatty acid induction of endothelial cell apoptosis
Yang, F., Cai, W., Yang, K., & Chen, M. (2012) · Cell Biochemistry and Function · doi:10.1002/cbf.2908 · Cited by 4
“While most studies of PKCδ demonstrate its role in the intrinsic apoptotic pathway, studies suggest that it can also regulate receptor-mediated cell death.(11) Previous reports have described associations between PKC activity and Fas-mediated apoptosis and Fas expression.”
BackgroundIn Vivo Effects of Antiviral Protein Kinase C Modulators on Zebrafish Development and Survival
Davis, R. V. N., McKernan, L. N., Rhodes, J., & Kulkosky, J. (2011) · ISRN Toxicology · doi:10.5402/2011/248280 · Cited by 4
“PMA, known to be a potent apoptotic mitogen for most cells and tissue systems [15, 16], exhibited the highest degree of inducing developmental defects and lethality relative to prostratin-treated specimens at the same concentration.”
Lipid‐Modulated Pharmacophore Nanorods Assembled at the Air/Water Interface
Philosof‐Mazor, L., Volinsky, R., Jopp, J., Blumberg, P. M., Rapaport, H., Márquez, V. E., & Jelinek, R. (2009) · ChemPhysChem · doi:10.1002/cphc.200900539 · Cited by 4
Diacylglycerol levels modulate the cellular distribution of the nicotinic acetylcholine receptor
Kamerbeek, C. B., Mateos, M. V., Vallés, A. S., Pediconi, M. F., Barrantes, F. J., & Borroni, V. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.02.010 · Cited by 5
Padma, D., & Bhat, K. M. R. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/15544.7115 · Cited by 4
“It is reported as a tumour promoter [7,8] but the usage of it has not been reduced as it is cheaper and efficient mitogen for melanocyte culture than other expensive growth factors like bFGF.”
BackgroundKrishnappa, K., Mallesh, N. K., Sharma, S. C., & Manjulakumari, D. (2017) · Frontiers in Biology · doi:10.1007/s11515-017-1475-x · Cited by 4
Xiao, X., Li, N., Wang, M., Xiong, C., Xie, D., Chu, X., Li, Y., Huang, Y., Ling, W., Li, Y., et al. (2020) · Journal of Nanoparticle Research · doi:10.1007/s11051-020-04864-0 · Cited by 4
“PMAwas widely used to induce the formation of tumor (Griner and Kazanietz 2007), but it was also applied to kill HL-60 cancer cells in coordination with electrochemiluminescence (ECL) technology and reactive oxygen species (ROS) (Zhang et al.”
MethodTarvainen, I., Nunn, R. C., Tuominen, R. K., Jäntti, M. H., & Talman, V. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000848 · Cited by 4
Tselios, C. P., Zaravinos, A., Tsartsalis, A. N., Tagka, A., Κωτούλας, Α., Geronikolou, S. A., Braoudaki, M., & Lambrou, G. Ι. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-78775-2_8 · Cited by 4
Fatty Acids - From Biosynthesis to Human Health
Froyen, E. (2022) · Biochemistry · doi:10.5772/intechopen.100947 · Cited by 5
Signaling Pathways Induced by G-protein-coupled Receptors
Rozengurt, E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00004-x · Cited by 5
The Role of Tpl2 Protein Kinase in Carcinogenesis and Inflammation
DeCicco-Skinner, K., Deshpande, M. M., & Wiest, J. S. (2012) · InTech eBooks · doi:10.5772/38135 · Cited by 4
“PKC is a multigene family of serine/threonine kinases (Griner and Kazanietz, 2007).”
Ali, F., Khan, A., Khan, R., & Sultana, S. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327115578865 · Cited by 4
“One of such mechanisms is the activation of protein kinase C (PKC), a family of serine/threonine protein kinases well known for their tumor-promoting abilities.(8) PKCs have versatile biological functions, including differentiation and cell cycle progression as well as apoptosis.”
BackgroundYang, M., Xing, S. J., Ou, H., Zhang, L., Shen, X., Xiong, G.-L., Wang, F.-M., Xiao, H., Tu, Y., Cong, Y., et al. (2018) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1421754 · Cited by 4
Syntheses of Asymmetrically Substituted Pyrans of Natural Origin
Szeja, W., & Grynkiewicz, G. (2018) · Springer eBooks · doi:10.1007/978-3-030-00545-0_7 · Cited by 4
Cellular and Molecular Mechanisms of Tumor Promotion
Sadler, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64273-3 · Cited by 4
Talman, V., Tuominen, R. K., af Gennäs, G. B., Yli‐Kauhaluoma, J. T., & Ekokoski, E. (2011) · PLoS ONE · doi:10.1371/annotation/7608bd2a-e319-47fd-ae20-478ee2875e27 · Cited by 4
Impinging Flow Mediates Vascular Endothelial Cell Injury through the PKCα/ERK/PPARγ Pathway in vitro
Xing, Z., Zheng, H., Zeng, Y., Tan, J., Zhang, Z., Zhao, Y., Zhu, H., & Li, M. (2024) · Cerebrovascular Diseases · doi:10.1159/000539000 · Cited by 3
“Ca 2+ Inhibitors Regulate MAPK Activation and Expression of PPAR γ , NF-κ B, and MMP2 by Inhibiting PKC α Phosphorylation Prior studies have indicated that the activation of PKC α is modulated by intracellular Ca 2+ concentration [8, 9, 25].”
MCPIP3 orchestrates the balance of epidermal proliferation and differentiation
Lichawska-Cieślar, A., Szukała, W., Pilat, P., Eckhart, L., Szepietowski, J. C., & Jura, J. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02184-1 · Cited by 3
“Aberrant PKC signaling has been implicated in many cellular processes related to carcinogenesis, including cell cycle regulation, apoptosis, differentiation, metastasis and angiogenesis [38].”
Synthesis and Biological Evaluation of Fluorescent Bryostatin Analogues
Cummins, T. J., Kedei, N., Czikora, Á., Lewin, N. E., Kirk, S. E. E., Petersen, M. E., McGowan, K. M., Chen, J., Luo, X., Johnson, R. C., et al. (2018) · ChemBioChem · doi:10.1002/cbic.201700655 · Cited by 3
Advanced Concepts and Perspectives of Membrane Physics
Sackmann, E. (2018) · Springer eBooks · doi:10.1007/978-3-030-00630-3_2 · Cited by 3
Stegen, M., Engler, A., Ochsenfarth, C., Manthey, I., Peters, J., Siffert, W., & Frey, U. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247087 · Cited by 3
Lambrou, G. Ι., Karakonstantakis, T., Vlahopoulos, S., & Zaravinos, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115889 · Cited by 3
“Such molecules include diacylglycerol [21], ceramides and sphingosine, molecules essential in cell proliferation and apoptosis [22], as well as pyridine nucleotides, with an essential role in signal transduction [23].”
BackgroundMolecular and therapeutic bases of cancer
Fajardo-Orduña, G. R., & Chamorro-Plata, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819828-5.00002-4 · Cited by 3
Biased signaling by mutant EGFR underlies dependence on PKCα in lung adenocarcinoma
Sadeghi, M., Salama, M., Chiappone, S. B., Huang, A., Resnick, A. E., Kandpal, M., Clarke, C. J., Haley, J. D., Davuluri, R. V., & Hannun, Y. A. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115026 · Cited by 4
Leondaritis, G., Koliou, X., Johnson, S., Li, C., Florakis, A., DIMAS, K. S., Sakellaridis, N., & Mangour, D. (2012) · InTech eBooks · doi:10.5772/27810 · Cited by 3
“PKCs are considered hubs for the transduction of signals from G protein-coupled and tyrosine kinase receptors (Parker & Murray-Rust, 2004; Griner and Kazanietz 2007), having long been recognized as a link between receptor-dependent generation of DAG by phospholipases C and D, and the key event for…”
BackgroundInfluentialHartjen, P., Höchst, B., Heim, D., Kammer, H., Lucke, J., Reinholz, M., Baier, A., Smeets, R., Wege, H., Borowski, P., et al. (2013) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-013-0099-7 · Cited by 3
“Our findings could be physiologically relevant because members of the PKC family play pivotal roles in cellular proliferation, apoptosis and cell survival, and there is a substantial amount of evidence linking disturbance of PKC to tumorigenesis [11].”
BackgroundKolen, K. V., Bruinzeel, W., He, W., KIMPE, N. D., Puyvelde, L. V., Cik, M., & Pullan, S. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.004 · Cited by 3
Meiler, J., Guyot, M., Hoffarth, S., Wesarg, E., Höhn, Y., Breitenbuecher, F., & Schüler, M. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1220-4 · Cited by 4
“1), which are considered critical for tumor growth and survival (Buchner 2000; Fabbro et al. 1999; Griner and Kazanietz 2007).”
BackgroundSugita, M., Kuwata, H., Kudo, I., & Hara, S. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.013 · Cited by 3
Li, X., Li, Y., Zhang, Y., Wang, K., Yuan, X., Jin, J., Zhang, Y., Liu, Z., & Chen, X. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.565393 · Cited by 3
“PKCs have a central role in cellular signaling transduction, involved in cell proliferation, differentiation, apoptosis, and angiogenesis [2].”
BackgroundSemsri, S. (2011) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp11.149 · Cited by 3
“Protein kinase C (PKC) is a family of serine/threonine protein and plays important roles in several diseases such as cancer, diabetes, stroke (Koivunen et al., 2006; Griner and Kazanietz, 2007).”
BackgroundWalker, J. W. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72843-6_8 · Cited by 3
“Phorbol esters potently and permanently activate many PKC isoforms as well as other signaling molecules (Griner and Kazanietz 2007), possibly contributing to non-specific phosphorylation.”
BackgroundRegulation and Function of Protein Kinase D Signaling
Rozengurt, E. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_7 · Cited by 3
Metadata
- Authors
- Griner, E. M., & Kazanietz, M. G.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Kazanietz, Marcelo G.
- Venue
- Nature Reviews Cancer
- Published
- 2007-04
- Volume
- 7
- Issue
- 4
- Pages
- 281-294
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1987496015
- Cited by
- 978
- References
- 190
- Citations by year
- 2026: 11 · 2025: 25 · 2024: 16 · 2023: 28 · 2022: 32 · 2021: 35 · 2020: 47 · 2019: 35 · 2018: 46 · 2017: 56 · 2016: 55 · 2015: 44 · 2014: 80 · 2013: 66 · 2012: 71
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- protein kinase C, diacylglycerol, phorbol ester, tumor promotion, carcinogenesis, tumor progression, cell cycle regulation, apoptosis, malignant transformation, cell survival, small GTPases, signal transduction
- MeSH terms
- Cell Cycle, Diglycerides, Enzyme Activation, Humans, Isoenzymes, Neoplasms, Neovascularization, Pathologic, Peptide Hydrolases, Phorbol Esters, Protein Kinase C, Apoptosis, GTP Phosphohydrolases, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.